Evidence map›Paper›PMID 41235297›Full record

ArticleJTO clinical and research reports2025

Characteristics of Short-Term Survivors With

Kai-Lin Liu, Alex Watts, Connor B Grady, Geoffrey Liu, Devalben Patel, Karmugi Balaratnam, Stephen V Liu, Gabriela Bravo Montenegro, Yunan Nie, Jorge Nieva and 23 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTO clinical and research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Kai-Lin LiuDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania.
Alex WattsDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Connor B GradyDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Geoffrey LiuDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Devalben PatelDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Karmugi BalaratnamDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Stephen V LiuDivision of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Gabriela Bravo MontenegroDivision of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Yunan NieDivision of Hematology and Oncology, University of Colorado Cancer Center, Aurora, Colorado.
Jorge NievaDivision of Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Amanda HerrmannDivision of Hematology-Oncology, University of California San Diego, San Diego, California.
Kristen MarroneDepartment of Oncology, Johns Hopkins Sidney Kimmer Comprehensive Cancer Center, Baltimore, Maryland.
Vincent LamDepartment of Oncology, Johns Hopkins Sidney Kimmer Comprehensive Cancer Center, Baltimore, Maryland.
Fangdi SunDepartment of Medicine, University of California San Francisco, San Francisco, California.
Jonathan DowellDepartment of Internal Medicine, University of Texas (UT) Southwestern Medical Center, Dallas Texas.
William SchwartzmanDepartment of Internal Medicine, University of Texas (UT) Southwestern Medical Center, Dallas Texas.
Vamsidhar VelchetiDepartment of Medicine, New York University (NYU) Grossman School of Medicine, New York University, New York, New York.
Olivia FankuchenDepartment of Medicine, New York University (NYU) Grossman School of Medicine, New York University, New York, New York.
Tasfiq UllahDepartment of Medicine, New York University (NYU) Grossman School of Medicine, New York University, New York, New York.
Liza VillaruzDivision of Hematology/Oncology, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania.
Matthew NguyenDivision of Hematology/Oncology, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania.
Jared WeissDivision of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Shetal PatelDivision of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Kelsey MillerDivision of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Wade IamsDivision of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Krishna ChandrasekharaDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania.
William TompkinsDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Tejas PatilDivision of Hematology and Oncology, University of Colorado Cancer Center, Aurora, Colorado.
Dara AisnerDivision of Hematology and Oncology, University of Colorado Cancer Center, Aurora, Colorado.
D Ross CamidgeDivision of Hematology and Oncology, University of Colorado Cancer Center, Aurora, Colorado.
Wei-Ting HwangDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Lova SunDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Melina E MarmarelisDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MELANIE H. COBB · 2010 to 2026
$53.7M
NCI NIH HHS P30 CA142543
6 · The paper itself

Abstract

Introduction: The prognostic significance of baseline and on-treatment brain and liver metastasis in Methods: Clinical characteristics and outcomes were abstracted from the electronic medical records of patients with Results: A total of 310 patients with Conclusions: Among patients with

Indexed as

ALKBrain metastasisLiver metastasisNSCLCROS1TKI

Identifiers

PMID41235297
PMCPMC12605057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.